PAI-1 (Plasminogen Activator Inhibitor-1) Expression Renders Alternatively Activated Human Macrophages Proteolytically Quiescent

被引:25
|
作者
Hohensinner, Philipp J. [1 ]
Baumgartner, Johanna [1 ]
Kral-Pointner, Julia B. [2 ]
Uhrin, Pavel [2 ]
Ebenbauer, Benjamin [1 ]
Thaler, Barbara [1 ]
Doberer, Konstantin [1 ]
Stojkovic, Stefan [1 ]
Demyanets, Svitlana [1 ,3 ]
Fischer, Michael B. [4 ,6 ]
Huber, Kurt [7 ,8 ]
Schabbauer, Gernot [2 ]
Speidl, Walter S. [1 ]
Wojta, Johann [1 ,5 ,8 ]
机构
[1] Med Univ Vienna, Dept Internal Med 2, Div Cardiol, Waehringer Guertel 18-20, A-1090 Vienna, Austria
[2] Med Univ Vienna, Ctr Physiol & Pharmacol, Inst Vasc Biol & Thrombosis Res, Vienna, Austria
[3] Med Univ Vienna, Dept Lab Med, Vienna, Austria
[4] Med Univ Vienna, Clin Blood Grp Serol & Transfus Med, Vienna, Austria
[5] Med Univ Vienna, Core Facil, Vienna, Austria
[6] Danube Univ Krems, Dept Hlth Sci & Biomed, Krems An der Donau, Austria
[7] Wilhelminenspital Stadt Wien, Dept Med 3, Vienna, Austria
[8] Ludwig Boltzmann Cluster Cardiovasc Res, Vienna, Austria
基金
奥地利科学基金会;
关键词
arteriosclerosis; macrophages; matrix metalloproteinases; serine proteases; serpins; HUMAN CARDIAC-CELLS; MATRIX METALLOPROTEINASES; MONONUCLEAR PHAGOCYTES; ENDOTHELIAL-CELLS; TISSUE-REPAIR; KAPPA-B; POLARIZATION; FIBROSIS; ATHEROSCLEROSIS; MONOCYTE;
D O I
10.1161/ATVBAHA.117.309383
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective-Macrophages are versatile immune cells capable of polarizing into functional subsets depending on environmental stimulation. In atherosclerotic lesions, proinflammatory polarized macrophages are associated with symptomatic plaques, whereas Th2 (T-helper cell type 2) cytokine-polarized macrophages are inversely related with disease progression. To establish a functional cause for these observations, we analyzed extracellular matrix degradation phenotypes in polarized macrophages. Approach and Results-We provide evidence that proinflammatory polarized macrophages rely on membrane-bound proteases including MMP-14 (matrix metalloproteinase-14) and the serine protease uPA (urokinase plasminogen activator) together with its receptor uPAR for extracellular matrix degradation. In contrast, Th2 cytokine alternatively primed macrophages do not show different proteolytic activity in comparison to unpolarized macrophages and lack increased localization of MMP-14 and uPA receptor to the cell membrane. Nonetheless, they express the highest amount of the serine protease uPA. However, uPA activity is blocked by similarly increased expression of its inhibitor PAI-1 (plasminogen activator inhibitor 1). When inhibiting PAI-1 or when analyzing macrophages deficient in PAI1, Th2 cytokine-polarized macrophages display the same matrix degradation capability as proinflammatory-primed macrophages. Within atherosclerotic lesions, macrophages positive for the alternative activation marker CD206 express high levels of PAI-1. In addition, to test changed tissue remodeling capacities of alternatively activated macrophages, we used a bleomycin lung injury model in mice reconstituted with PAI-1(-/-) bone marrow. These results supported an enhanced remodeling phenotype displayed by increased fibrosis and elevated MMP activity in the lung after PAI-1 loss. Conclusions-We were able to demonstrate matrix degradation dependent on membrane-bound proteases in proinflammatory stimulated macrophages and a forced proteolytical quiescence in alternatively polarized macrophages by the expression of PAI-1. Visual Overview-An online visual overview is available for this article.
引用
收藏
页码:1913 / +
页数:22
相关论文
共 50 条
  • [1] Plasminogen activator inhibitor-1 (PAI-1) expression in endometriosis
    Alotaibi, Fahad T.
    Peng, Bo
    Klausen, Christian
    Lee, Anna F.
    Abdelkareem, Amr O.
    Orr, Natasha L.
    Noga, Heather
    Bedaiwy, Mohamed A.
    Yong, Paul J.
    PLOS ONE, 2019, 14 (07):
  • [2] PAI-1 EXPRESSION RENDERS M2 POLARIZED MACROPHAGES PROTEOLYTICALLY QUIESCENT
    Hohensinner, P.
    Baumgartner, J.
    Ebenbauer, B.
    Thaler, B.
    Konstantin, D.
    Kaun, C.
    Stoijkovic, S.
    Fischer, M.
    Maurer, G.
    Huber, K.
    Wojta, J.
    ATHEROSCLEROSIS, 2016, 252 : E219 - E220
  • [3] Gene expression of Plasminogen Activator Inhibitor-1 (PAI-1) in human ciliary processes and determination of PAI-1 in human aqueous humor
    Meyer, MW
    Depka, M
    Wilhelm, C
    Meyer, A
    Erb, C
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46
  • [4] STABILITY OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1)
    LINDAHL, TL
    SIGURDARDOTTIR, O
    WIMAN, B
    THROMBOSIS AND HAEMOSTASIS, 1989, 62 (02) : 748 - 751
  • [5] THE ACTIVITY OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) OF HUMAN PLATELET
    BOOTH, NA
    CROLL, A
    BENNETT, B
    FIBRINOLYSIS, 1990, 4 : 138 - 140
  • [6] Significance of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 (PAI-1) expression in human colorectal carcinomas
    Papadopoulou, S
    Scorilas, A
    Yotis, J
    Arnogianaki, N
    Plataniotis, G
    Agnanti, N
    Talieri, M
    TUMOR BIOLOGY, 2002, 23 (03) : 170 - 178
  • [7] Plasminogen-activator inhibitor-1 in (PAI-1) gastric cancer
    Tabuchi, Y
    Nakamura, T
    Miyamura, K
    Nakae, S
    PROGRESS IN GASTRIC CANCER RESEARCH 1997: PROCEEDINGS OF THE 2ND INTERNATIONAL GASTRIC CANCER CONGRESS, 1997, : 447 - 450
  • [8] Genetics of Plasminogen Activator Inhibitor-1 (PAI-1) in a Ghanaian Population
    White, Marquitta J.
    Kodaman, Nuri M.
    Harder, Reed H.
    Asselbergs, Folkert W.
    Vaughan, Douglas E.
    Brown, Nancy J.
    Moore, Jason H.
    Williams, Scott M.
    PLOS ONE, 2015, 10 (08):
  • [9] The international standard for plasminogen activator inhibitor-1 (PAI-1) activity
    Gaffney, PJ
    Edgell, TA
    THROMBOSIS AND HAEMOSTASIS, 1996, 76 (01) : 80 - 83
  • [10] Modulation of plasminogen activator inhibitor-1 (PAI-1) by the naphthoquinone shikonin
    Han, Tingting
    Zhang, Guangping
    Yan, Dong
    Yang, Hong
    Ma, Tonghui
    Ye, Zuguang
    FITOTERAPIA, 2016, 113 : 117 - 122